A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub -study SWOG S1400C.

被引：8
|
作者：
Edelman, Martin J.
Redman, Mary Weber
Albain, Kathy S.
McGary, Eric C.
Rafique, Norman
Petro, Daniel P.
Waqar, Saiama Naheed
Miao, Jieling
Griffin, Katie
Papadimitrakopoulou, Vassiliki
Kelly, Karen
Gandara, David R.
Herbst, Roy S.
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Loyola Univ, Chicago Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA
[4] Kaiser Permanente, Cadillac, CA USA
[5] Tricty Hematol Oncol Associates, Mercy Med Ctr, Massilon, OH USA
[6] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA
[7] Washington Univ, Div Oncol, Dept Med, Sch Med, St Louis, MO USA
[8] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[10] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA
[11] Univ Calif Davis, Sacramento, CA 95817 USA
[12] Yale Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.9056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9056
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer
    Atagi, Shinji
    Kawahara, Masaaki
    Kusunoki, Yoko
    Takada, Minoru
    Kawaguchi, Tomoya
    Okishio, Kyoiti
    Kubo, Akihito
    Uehira, Kazutaka
    Yumine, Katsuyuki
    Tomizawa, Yoshio
    Saito, Ryusei
    Fukai, Shimao
    Komatsu, Hikotaro
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) : 1012 - 1017
  • [42] Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer
    Wada, M.
    Yamamoto, M.
    Ryuge, S.
    Nagashima, Y.
    Hayashi, N.
    Maki, S.
    Otani, S.
    Katono, K.
    Takakura, A.
    Yanaihara, T.
    Igawa, S.
    Yokoba, M.
    Mitsufuji, H.
    Kubota, M.
    Katagiri, M.
    Masuda, N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1005 - 1011
  • [43] Randomized phase II study of pemetrexed versus gefitinib in previously treated patients with advanced no small cell lung cancer
    Kim, Young Saing
    Cho, Eun Kyung
    Sym, Sun Jin
    Hong, Junshik
    Park, Lnkeun
    Ahn, Lee Kyung
    Park, Jeong Woong
    Jung, Sung Hwan
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] A phase II study of weekly irinotecan and capecitabine in patients with previously treated non-small cell lung cancer
    Han, JY
    Lee, DH
    Kim, HY
    Kim, EA
    Lee, JJ
    Ju, SY
    Shin, EH
    Lee, JS
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 5909 - 5914
  • [45] PHASE-II STUDY OF VINORELBINE (NAVELBINE) IN PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER PATIENTS
    JASSEM, J
    KARNICKAMLODKOWSKA, H
    VANPOTTELSBERGHE, C
    VANGLABBEKE, M
    NOSEDA, MA
    ARDIZZONI, A
    GOZZELINO, F
    PLANTING, A
    VANZANDWIJK, N
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1720 - 1722
  • [46] Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
    Parra, Edwin Roger
    Zhang, Jiexin
    Duose, Dzifa Yawa
    Gonzalez-Kozlova, Edgar
    Redman, Mary W.
    Chen, Hong
    Manyam, Ganiraju C.
    Kumar, Gayatri
    Zhang, Jianhua
    Song, Xingzhi
    Lazcano, Rossana
    Marques-Piubelli, Mario L.
    Laberiano-Fernandez, Caddie
    Rojas, Frank
    Zhang, Baili
    Taing, Len
    Jhaveri, Aashna
    Geisberg, Jacob
    Altreuter, Jennifer
    Michor, Franziska
    Provencher, James
    Yu, Joyce
    Cerami, Ethan
    Moravec, Radim
    Kannan, Kasthuri
    Luthra, Rajyalakshmi
    Alatrash, Gheath
    Huang, Hsin-Hui
    Xie, Hui
    Patel, Manishkumar
    Nie, Kai
    Harris, Jocelyn
    Argueta, Kimberly
    Lindsay, James
    Biswas, Roshni
    Van Nostrand, Stephen
    Kim-Schulze, Seunghee
    Gray, Jhanelle E.
    Herbst, Roy S.
    Wistuba, Ignacio I.
    Gettinger, Scott
    Kelly, Karen
    Bazhenova, Lyudmila
    Gnjatic, Sacha
    Lee, J. Jack
    Zhang, Jianjun
    Haymaker, Cara
    CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1655 - 1668
  • [47] A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer
    Agelaki, S
    Syrigos, K
    Christophylakis, C
    Boukovinas, J
    Varthalitis, J
    Pavlakou, G
    Athanasiadis, A
    Kouroussis, C
    Vardakis, N
    Maltezakis, G
    Milaki, G
    Georgoulias, V
    ONCOLOGY, 2004, 66 (03) : 192 - 196
  • [48] Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: A multicentre phase II study
    Rapti, A
    Agelidou, A
    Stergiou, I
    Agelidou, M
    Nikolakopoulos, L
    Varthalitis, J
    Kalykaki, A
    Chainis, K
    Tzanakis, N
    Georgoulias, V
    LUNG CANCER, 2005, 49 (02) : 241 - 244
  • [49] A PHASE-II STUDY OF CARBOPLATIN AND VINCRISTINE IN PREVIOUSLY TREATED PATIENTS WITH SMALL-CELL LUNG-CANCER
    SMIT, EF
    BERENDSEN, HH
    DEVRIES, EGE
    MULDER, NH
    POSTMUS, PE
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (03) : 202 - 204
  • [50] Infiltration and spatial distribution of immune cells are associated clinical benefit from Nivolumab and Ipilimumab for previously treated patients with stage IV squamous cell lung cancer: an immune biomarker analysis of Phase III SWOG LungMAP S1400I trial
    Parra, Edwin Roger
    Zhang, Jiexin
    Redman, Mary
    Lazcano, Rossana
    Mario, Piubelli
    Fernandez, Caddie Laberiano
    Krishna, Renganayaki K.
    Zhang, Shanyu
    Chen, Hong
    Manyam, Ganiraju
    Moravec, Radim
    Cerami, Ethan
    Lindsay, James
    Yu, Joyce
    Biswas, Roshni
    Van Nostrand, Stephen
    Duose, Dzifa Y.
    Zhang, Jianjun
    Herbst, Roy
    Al-Atrash, Gheath
    Kannan, Kasthuri
    Wistuba, Ignacio I.
    Gettinger, Scott
    Bazhenova, Lyudmila
    Lee, Jack
    Zhang, Jianhua
    Haymaker, Cara
    CANCER RESEARCH, 2022, 82 (12)
12345